First tranche delivered, larger tranches en route: the same engine that just produced has visibly more already scheduled
The model's full reasoning — Q4 2022 call → NOWe need answer YES/NO. Need analyze transcript. Need identify engine of new business with first tranche landed and larger tranches in motion same engine. Need be strict. Let's parse. Management describes MRD growth, clonoSEQ, DLBCL launch, Epic integration, Genentech programs, pharma services, drug discovery. Need find one specific engine where first tranche actually delivered in reported period and larger tranches already committed/scheduled/ramping, remainder larger. Potential: Genentech collaboration? They have two cell therapy programs. First shared TCR candidates selected by Genentech, focus speed to clinic. Delivered two additional shared TCR data packages for Genentech's consideration. Fully personalized program prototype with >60 patients, identified TCRs, completed end-to-end process runs. This year standardizing/optimizing towards clinical readiness. But no revenue? They recognized milestones? Genentech amortization. But "first tranche landed" maybe data packages delivered? Larger tranches? Not clear. Potential: clonoSEQ DLBCL launch. Launched at ASH December. Anticipate DLBCL meaningful contributor in second half 2023. But no first tranche landed? Launch is product available, but not described as actual delivered tests? They have Medicare coverage only, expect private payer coverage. Not enough. Potential: Epic integration. Signed agreement with Epic for EMR integration. Expected back half. Not landed. Potential: MRD pharma partnerships. Quarterly revenue excluding regulatory milestones grew 52% vs prior year and 41% vs prior quarter. Recognized $2 million milestone from approval of multiple myeloma therapy. But that's milestone, not engine with larger tranches? They have future milestones $370 million, half line of sight, risk adjusted. But not specific engine. Potential: clonoSEQ blood-based testing. Blood-based testing currently ~1/3 of tests. They expect increase. Not specific engine. Potential: Community expansion. Community now 15% vs 12% last quarter. Expect 20% in 2023. Is that an engine? First tranche landed? Community business grew from 8% to 15% over 2022. Larger tranches in motion? They expect 20% in 2023. But is that "already committed, scheduled, contracted"? It's a projection, not secured. Also routine? No. Potential: Sales team doubled. Not engine. Potential: Pharma services. Substantial growth 67% vs 2021. But no specific engine.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| ATAT | Atour Lifestyle Holdings Limited | Q1 2024 | 2024-05-23 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| ZLAB | Zai Lab Limited | Q4 2023 | 2024-02-28 | C |
| VMI | Valmont Industries, Inc. | Q4 2023 | 2024-02-22 | C |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| CLNE | Clean Energy Fuels Corp. | Q2 2023 | 2023-08-09 | C+ |
| LUCD | Lucid Diagnostics Inc. | Q1 2023 | 2023-05-16 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| ARE | Alexandria Real Estate Equities, Inc. | Q4 2022 | 2023-01-31 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| FEIM | Frequency Electronics, Inc. | Q1 2019 | 2018-09-13 | B+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MGA | Magna International Inc. | Q1 2018 | 2018-05-10 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| HR | Healthcare Realty Trust Incorporated | Q1 2017 | 2017-05-08 | A |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| MTRX | Matrix Service Company | Q3 2016 | 2016-05-05 | D |
| CLF | Cleveland-Cliffs Inc. | Q1 2016 | 2016-04-29 | F |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
CDMO · Q3 2022 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: NO The transcript describes the first phase of the Myford expansion as now operational and scheduling client projects, with management noting they are already utilizing the new space and that an extra $5 million is arguably in backlog attributable to it.
LINC · Q1 2024 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: YES The transcript identifies the new-campus expansion strategy as the engine. East Point opened in Q1 with 29 starts and $90k revenue (first tranche, concrete and delivered).
LTRX · Q3 2024 → YESThe question is about whether management describes one identifiable engine of new business that meets two criteria: a first tranche has actually landed in the just-reported period, and larger tranches...